KCNA3 and melanoma: In contrast to the membrane-impermeant Kv1.3 inhibitor margatoxin, PAPTP and PCARBTP reduced cell viability and efficiently killed B16F10 melanoma cells, underlining the notion that the novel Kv1.3 inhibitors act by targeting Kv1.3 in mitochondria.